Dow Up 0.59% Nasdaq Up 0.75%

CTI BioPharma Corp. (CTIC)

-NasdaqCM
2.51 Up 0.01(0.40%) 4:00PM EDT
Prev Close:2.50
Open:2.48
Bid:2.48 x 800
Ask:2.76 x 1300
1y Target Est:5.08
Beta:1.64
Earnings Date:Oct 28 - Nov 3 (Est.)
Day's Range:2.45 - 2.52
52wk Range:1.21 - 4.25
Volume:596,430
Avg Vol (3m):1,171,740
Market Cap:362.58M
P/E (ttm):N/A
EPS (ttm):-0.48
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for CTIC

Comparison

Symbol% ChgMkt Cap
CTICUp 0.40%362.58M
BMYUp 2.40%84.80B
RHHBYUp 1.41%254.67B
SNYUp 0.12%147.43B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):10.03
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.61
Quarterly EPS Est (Sep-14) :-0.05
Mean Recommendation*:1.7
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

CTI BioPharma Corp., a biopharmaceutical company, is engaged in the acquisition, development, and commercialization of treatments for cancer. It primarily focuses on the commercialization of PIXUVRI, an aza-anthracenedione derivative, which is in ... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback